This work is licensed under the Creative Commons Attribution 4.0 International License.
Schläfke ME, Pokorski M, See WR, Prill RK, Loeschcke HH. Chemosensitive neurons on the ventral medullary surface. Bull Physiopathol Respir (Nancy). 1975;11(2):277–84.SchläfkeMEPokorskiMSeeWRPrillRKLoeschckeHHChemosensitive neurons on the ventral medullary surface197511227784Search in Google Scholar
Demartini Junior Z, Gatto LAM, Koppe GL, Francisco AN, Guerios EE. Ondine’s curse: myth meets reality. Sleep Med: X 2. 2020;100012.Demartini JuniorZGattoLAMKoppeGLFranciscoANGueriosEEOndine’s curse: myth meets reality202010001210.1016/j.sleepx.2020.100012804113233870169Search in Google Scholar
Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006; 117(6):1979-87.ClarkRHBloomBTSpitzerARGerstmannDRReported medication use in the neonatal intensive care unit: data from a large national data set2006117619798710.1542/peds.2005-170716740839Search in Google Scholar
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112–21.SchmidtBRobertsRSDavisPet alCaffeine therapy for apnea of prematurity20063542021122110.1056/NEJMoa05406516707748Search in Google Scholar
Dobson NR, Hunt CE. Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. NeoReviews. 2003;14;e540-50.DobsonNRHuntCEPharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes200314e5405010.1542/neo.14-11-e540Search in Google Scholar
Bellingham MC. Driving respiration: the respiratory central pattern generator. Clin Exp Pharmacol Physiol. 1998;25(10):847-56.BellinghamMCDriving respiration: the respiratory central pattern generator199825108475610.1111/j.1440-1681.1998.tb02166.x9784928Search in Google Scholar
Piper AJ, Yee BJ. Hypoventilation syndromes. Compr Physiol. 2014;4(4):1639-76.PiperAJYeeBJHypoventilation syndromes20144416397610.1002/cphy.c14000825428856Search in Google Scholar
Schrader L, Horsfall J, Bookheimer S. Use of caffeine during intraoperative awake language mapping. J Clin Neurophysiol. 2011;28(4):424–9.SchraderLHorsfallJBookheimerSUse of caffeine during intraoperative awake language mapping20112844249Search in Google Scholar
Gouda NM. Intravenous caffeine for adult patients with obstructive sleep apnea undergoing uvulopalatopharyngoplasty: effects on postoperative respiratory complications and recovery profile. Med J Cairo Univ. 2010;78:155–9.GoudaNMIntravenous caffeine for adult patients with obstructive sleep apnea undergoing uvulopalatopharyngoplasty: effects on postoperative respiratory complications and recovery profile2010781559Search in Google Scholar
Warner NS, Warner MA, Schroeder DR, Sprung J, Weingarten TN. Effects of caffeine administration on sedation and respiratory parameters in patients recovering from anesthesia. Bosn J Basic Med Sci. 2018 Feb; 18(1): 101–104.WarnerNSWarnerMASchroederDRSprungJWeingartenTNEffects of caffeine administration on sedation and respiratory parameters in patients recovering from anesthesia2018Feb;18110110410.17305/bjbms.2018.2434582666829206091Search in Google Scholar
Fong R, Wang L, Zacny JP, Khokhar S, Apfelbaum JL, Fox AP, et al. Caffeine accelerates emergence from Isoflurane anesthesia in humans: a randomized, double-blind, crossover study. Anesthesiol. 2018;129(5):912–20.FongRWangLZacnyJPKhokharSApfelbaumJLFoxAPet alCaffeine accelerates emergence from Isoflurane anesthesia in humans: a randomized, double-blind, crossover study201812959122010.1097/ALN.0000000000002367619131630044241Search in Google Scholar
Lexi-drugs online [database on the Internet]. Hudson (OH): Lexi-Comp, Inc.; 2019. Available from: http://online.lexi.com (Accessed on 19 Jan 2022).Hudson (OH)Lexi-Comp, Inc2019Available fromhttp://online.lexi.com(Accessedon 19 Jan 2022)Search in Google Scholar
Bairam A, Uppari N, Mubayed S, Joseph V. An overview on the respiratory stimulant effects of caffeine and progesterone on response to hypoxia and apnea frequency in developing rats. Adv Exp Med Biol. 2015;860:211-20.BairamAUppariNMubayedSJosephVAn overview on the respiratory stimulant effects of caffeine and progesterone on response to hypoxia and apnea frequency in developing rats20158602112010.1007/978-3-319-18440-1_2326303483Search in Google Scholar
Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281.DerryCJDerrySMooreRACaffeine as an analgesic adjuvant for acute pain in adults201412CD00928110.1002/14651858.CD009281.pub3648570225502052Search in Google Scholar
Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Reviews Neuroscience. 2003;4(5):399–415.LoEHDalkaraTMoskowitzMAMechanisms, challenges and opportunities in stroke20034539941510.1038/nrn110612728267Search in Google Scholar
Feeney D. M., Baron J. C. Diaschisis. Stroke. 1986;17(5):817– 830.FeeneyD. M.BaronJ. C.Diaschisis198617581783010.1161/01.STR.17.5.8173532434Search in Google Scholar
Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology. 2018;128:102737.DahanAvan derSchrier RSmithTAartsLvan VelzenMNiestersM.Averting opioid-induced respiratory depression without affecting analgesia201812810273710.1097/ALN.000000000000218429553984Search in Google Scholar
Stanley NN, Galloway JM, Flint KC, Campbell DB. Increased respiratory chemosensitivity in patients with chronic airways obstruction. Br J Dis Chest. 1983;77:136-46.StanleyNNGallowayJMFlintKCCampbellDBIncreased respiratory chemosensitivity in patients with chronic airways obstruction1983771364610.1016/0007-0971(83)90019-06871083Search in Google Scholar
Gaudy JH, Dauthier C, Fourgeaux B. Effect of a new analeptic drug, almitrine, on fentanyl-induced respiratory depression and analgesia in man. Br J Anaesth. 1982;54:617-21.GaudyJHDauthierCFourgeauxBEffect of a new analeptic drug, almitrine, on fentanyl-induced respiratory depression and analgesia in man1982546172110.1093/bja/54.6.6176123336Search in Google Scholar
European Medicines Agency Communication: Oral almitrine to be withdrawn by EU member states. EMEA/313994, 2013. [updated 2013 May 31; cited 2022 Feb 9]. Available from:www. ema.europa.eu/ema/index.jsp?curl=pages/medicines/ human/referrals/Almitrine/human_referral_prac_000011. jsp&mid=WC0b01ac05805c516f.2013[updated 2013 May 31; cited 2022 Feb 9]. Available fromwww.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Almitrine/human_referral_prac_000011jsp&mid=WC0b01ac05805c516fSearch in Google Scholar
Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6.KimDWJooJDInJHJeonYSJungHSJeonKBParkJSChoiJWComparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil201325173610.1016/j.jclinane.2012.07.00523583458Search in Google Scholar
Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lotsch J. The partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine induced respiratory depression in humans. Clin Pharmacol Ther. 2007;81:59-68.OertelBGSchneiderARohrbacherMSchmidtHTegederIGeisslingerGLotschJThe partial 5-hydroxytryptamine 1A receptor agonist buspirone does not antagonize morphine induced respiratory depression in humans200781596810.1038/sj.clpt.610001817186000Search in Google Scholar
Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr Opin Pharmacol. 2006;6:82-88.LynchGGlutamate-based therapeutic approaches: ampakines20066828810.1016/j.coph.2005.09.00516361116Search in Google Scholar
Oertel BG, Felden L, Tran PV, Bradshaw MH, Angst MS, Schmidt H, Johnson S, Greer JJ, Geisslinger G, Varney MA, Lötsch J. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther. 2010;87(2):204-11.OertelBGFeldenLTranPVBradshawMHAngstMSSchmidtHJohnsonSGreerJJGeisslingerGVarneyMALötschJSelective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia20108722041110.1038/clpt.2009.19419907420Search in Google Scholar
Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology. 1975;42:559-66.MitchellRAHerbertDAPotencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats1975425596610.1097/00000542-197505000-000091130721Search in Google Scholar
Kim DW, Joo JD, In JH, Jeon YS, Jung HS, Jeon KB, Park JS, Choi JW. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil. J Clin Anesth. 2013;25:173-6.KimDWJooJDInJHJeonYSJungHSJeonKBParkJSChoiJWComparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil201325173610.1016/j.jclinane.2012.07.00523583458Search in Google Scholar
Gairola RL, Gupta PK, Pandley K. Antagonists of morphine induced respiratory depression: a study in postoperative patients. Anaesthesia. 1980;35:17-21.GairolaRLGuptaPKPandleyKAntagonists of morphine induced respiratory depression: a study in postoperative patients198035172110.1111/j.1365-2044.1980.tb03714.x6994518Search in Google Scholar
Roozekrans M, Olofsen E, van der Schrier R, Boom M, Mooren R, Dahan A. Doxapram-mediated increase in cardiac output reduces opioid plasma concentrations. A PK-PD/PK-PD modeling study in healthy volunteers. Clin Pharmacol Ther. 2017;102:115-22.RoozekransMOlofsenEvan der SchrierRBoomMMoorenRDahanADoxapram-mediated increase in cardiac output reduces opioid plasma concentrations. A PK-PD/PK-PD modeling study in healthy volunteers20171021152210.1002/cpt.60128001306Search in Google Scholar
Stephen CR, Talton I. Investigation of doxapram as a postanesthetic respiratory stimulant. Anesthesia & Analgesia. 1964;43:628-40.StephenCRTaltonIInvestigation of doxapram as a postanesthetic respiratory stimulant1964436284010.1213/00000539-196411000-00006Search in Google Scholar
Abelson JL, Nesse RM, Weg JG, Curtis GC. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosomatic Medicine. 1996a;58:302-13.AbelsonJLNesseRMWegJGCurtisGCRespiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic1996a583021310.1097/00006842-199607000-000028827792Search in Google Scholar
Abelson JL, Weg JG, Nesse RM, Curtis GC. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology. 1996b;21:375-90.AbelsonJLWegJGNesseRMCurtisGCNeuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model1996b213759010.1016/0306-4530(96)00005-48844876Search in Google Scholar
Miyata M, Hata T, Kato N, Takeuchi M, Mizutani H, Kubota M, Yamazaki T. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride. Journal of Perinatal Medicine. 2007;35.MiyataMHataTKatoNTakeuchiMMizutaniHKubotaMYamazakiTDynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride20073510.1515/JPM.2007.06817614751Search in Google Scholar
Jonkman K, van Rijnsoever E, Olofsen E, et al. Esketamine counters opioid-induced respiratory depression. Br J Anaesth. 2018;120(5):1117-27.JonkmanKvan RijnsoeverEOlofsenEet alEsketamine counters opioid-induced respiratory depression2018120511172710.1016/j.bja.2018.02.02129661389Search in Google Scholar
McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, Rowe IC. A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Caactivated K (BK) channel alpha-subunits. Proc Natl Acad Sci USA. 2005;102:17870-6.McCartneyCEMcClaffertyHHuibantJMRowanEGShipstonMJRoweICA cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Caactivated K (BK) channel alpha-subunits200510217870610.1073/pnas.0505270102130889316306267Search in Google Scholar
Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology. 2014;121:459-68.RoozekransMvan der SchrierROkkersePHayJMcLeodJFDahanATwo studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers20141214596810.1097/ALN.000000000000036725222672Search in Google Scholar
Roozekrans M, Olofsen E, van der Schrier R, van Gerven J, Peng S, McLeod J, Dahan A. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokineticpharmacodynamic modeling study in healthy volunteers. Clin Pharmacol Ther. 2015;97:641-9.RoozekransMOlofsenEvan der SchrierRvan GervenJPengSMcLeodJDahanAReversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokineticpharmacodynamic modeling study in healthy volunteers201597641910.1002/cpt.9925704491Search in Google Scholar